27-Mar-2024
No headlines found.
Globe Newswire (Mon, 18-Mar 7:30 AM ET)
Abeona Therapeutics Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Globe Newswire (Tue, 5-Mar 7:30 AM ET)
Abeona Therapeutics Announces Progress Update on Pz-cel Biologics License Application (BLA)
Globe Newswire (Thu, 1-Feb 7:30 AM ET)
Abeona Therapeutics Announces $50 Million Credit Facility
Globe Newswire (Mon, 8-Jan 7:30 AM ET)
Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its clinical programs consist of pz-cel, an autologous, engineered cell therapy currently in development for recessive dystrophic epidermolysis bullosa (RDEB). The Company's development portfolio also features adeno-associated virus (AAV)-based gene therapies designed to treat unmet, medically needed ophthalmic diseases using the novel AIM.
Abeona Therapeutics trades on the NASDAQ stock market under the symbol ABEO.
As of March 27, 2024, ABEO stock price declined to $7.34 with 129,293 million shares trading.
ABEO has a beta of 0.24, meaning it tends to be less sensitive to market movements. ABEO has a correlation of 0.00 to the broad based SPY ETF.
ABEO has a market cap of $200.79 million. This is considered a Small Cap stock.
In the last 3 years, ABEO stock traded as high as $51.00 and as low as $2.19.
The top ETF exchange traded funds that ABEO belongs to (by Net Assets): VTI, VXF, ITOT, IWC, DFAS.
ABEO has outperformed the market in the last year with a return of +169.9%, while the SPY ETF gained +33.6%. In the last 3 month period, ABEO beat the market returning +43.4%, while SPY returned +10.1%. However, in the most recent 2 weeks ABEO has underperformed the stock market by returning -10.8%, while SPY returned +1.7%.
ABEO support price is $6.96 and resistance is $7.77 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that ABEO stock will trade within this expected range on the day.